Skip to main content

Has venetoclax been funded by Pharmac for the treatment of acute myeloid leukaemia in patients who are unfit for intensive chemotherapy, if not, is it under consideration for funding?

Answered Question 18919 (2026)
Question published
Reply lodged
Bookmark

Asked by

Ayesha Verrall

List MP · Labour Party

Question

  • Has venetoclax been funded by Pharmac for the treatment of acute myeloid leukaemia in patients who are unfit for intensive chemotherapy, if not, is it under consideration for funding?

Answered by

Hon David Seymour

Member for Epsom · ACT Party · Associate Minister of Health

Answer

Yes, venetoclax is funded by Pharmac for the treatment of acute myeloid leukaemia in patients who are unable to receive intensive chemotherapy. I am advised by Pharmac it has been funded since 1 May 2025. I refer the Member to the following link for more information: https://www.pharmac.govt.nz/news-and-resources/consultations-and-decisions/2025-04-decision-to-widen-access-to-medicines-for-blood-cancer-inflammatory-bowel-diseases-eczema-and-rheumatoid-arthritis